Company profile: Fantex
1.1 - Company Overview
Company description
- Provider of polymeric biocide technology designed to combat bacteria and infectious diseases. Fantex technology represents a new generation and class of biocides that exploit natural bio-defence-mimetics and work differently from chemical biocides by using a novel method of bacterial cell killing.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Fantex
Glympse Bio
HQ: United States
Website
- Description: Provider of noninvasive, predictive diagnostic solutions for monitoring multiple human diseases, using precisely engineered diagnostic agents that interrogate the body for disease states and carry the message to the urine for analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Glympse Bio company profile →
Nextal Biotech
HQ: United States
Website
- Description: Provider of products designed for experimental crystallization needs, offering plates with grease-free, independent, screwable crystallization supports.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nextal Biotech company profile →
Carterra
HQ: United States
Website
- Description: Provider of biotechnology solutions for micro-array deposition technologies, delivering instruments and services that enable multiplexing on planar array surfaces. Offerings include LSA and LSAXT for monoclonal antibody characterization (kinetics, epitope binning), Continuous Flow Microspotter (CFM), sensor chips, kinetics and epitope software, and AI/ML in silico tools for drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Carterra company profile →
Afyren
HQ: France
Website
- Description: Provider of biotechnological and green chemistry solutions that valorize non-food biomass into biosourced molecules and natural organic acids. Offers AFYREN NEOXY production facility, FLAVYREN flavor and fragrance acids with a low carbon footprint, and a circular eco approach using organic waste and aiming for zero industrial waste via by-product valorization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Afyren company profile →
Xlife Sciences
HQ: Switzerland
Website
- Description: Provider of development and commercialization of early-stage life sciences research from universities and research institutions, bridging R&D to healthcare markets. Offers technology platforms, biotechnologies and therapies addressing unmet medical needs, medical technologies, artificial intelligence in life sciences, and digital health projects to enhance healthcare and life quality.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xlife Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Fantex
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Fantex
2.2 - Growth funds investing in similar companies to Fantex
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Fantex
4.2 - Public trading comparable groups for Fantex
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →